Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal
Open accessThe DOI matches its Crossref record.
Abstract
Forty-seven patients with autoimmune chronic active hepatitis in remission on azathioprine and/or prednisolone were entered into a randomized controlled trial to assess the value of azathioprine alone in maintenance of remission. The trial design involved administering azathioprine at a dose of 2 mg per kg to one-half of the patients, in whom prednisolone was then gradually withdrawn, whereas the remaining patients, the “control” group, were maintained on the conventional combination regimen of azathioprine (1 mg per kg) with prednisolone. At 1 year there was no significant difference in respect of standard liver function tests or histological appearances between the two groups. Two patients in the azathioprine group required dosage reduction because of myelosuppression and both subsequently relapsed. Following withdrawal of corticosteroids Cushingoid features were lost with a return of weight and blood pressure to normality. In 75% of the patients, corticosteroid withdrawal was marked by arthralgias and myalgias which lasted for up to 12 months: no other major side effects of corticosteroid withdrawal were noted. Thus in the majority of cases, remissions in autoimmune chronic active hepatitis which are induced by corticosteroids can be maintained with azathioprine alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
“The data regarding maintenance therapy with azathioprine monotherapy at a dosage of 2 mg/kg/day are encouraging in terms of prevention of steroid specific side effects and relapse, with no relapse during azathioprine maintenance therapy after one year and 83% remission rate over a median follow-up of 67 months [179,22…”
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Self-citationDiagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 563
Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331502 · Cited by 382
Self-citationAutoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *
Feld, J. J., Dinh, H., Arenovich, T., Marcus, V. A., Wanless, I. R., & Heathcote, J. E. (2005) · Hepatology · doi:10.1002/hep.20732 · Cited by 367
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Czaja, A. J., & Manns, M. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.053 · Cited by 280
Heneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D., & Longhi, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62163-1 · Cited by 277
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
Gleeson, D., & Heneghan, M. A. (2011) · Gut · doi:10.1136/gut.2010.235259 · Cited by 275
Management and outcome of pregnancy in autoimmune hepatitis
Heneghan, M. A., Norris, S. M., O'Grady, J. G., Harrison, P. M., & McFarlane, I. G. (2001) · Gut · doi:10.1136/gut.48.1.97 · Cited by 253
Self-citationPape, S., Snijders, R. J. A. L. M., Gevers, T. J. G., Chazouilleres, O., Dalekos, G. N., Hirschfield, G. M., Lenzi, M., Trauner, M., Manns, M. P., Vierling, J. M., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.041 · Cited by 177
Randomized discontinuation trials: Utility and efficiency
Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90163-u · Cited by 134
Metadata
- Authors
- Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R.
- Venue
- Hepatology
- Published
- 1988-07
- Volume
- 8
- Issue
- 4
- Pages
- 781-784
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2127814283
- Cited by
- 135
- References
- 0
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.